CClinicalTrials.gg
RecruitingNCT05986032REACTUpdated Mar 6, 2024

Respiratory Oscillometry for the Prediction of Bronchopulmonary Dysplasia

An observational study in Bronchopulmonary Dysplasia, sponsored by Fondazione IRCCS San Gerardo dei Tintori. Recruiting at 6 sites in 5 countries. Open to participants aged 5 Days to 9 Days. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by Fondazione IRCCS San Gerardo dei Tintori · Observational

From the registry’s dates

  • Primary completion was expected by Sep 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Started Jul 2023; still recruiting 3 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
150
Ages
5 Days to 9 Days
Sex
All
01

Study summary

The goal of this observational study is to learn about the correlation between respiratory system reactance, as assessed by respiratory oscillometry, and respiratory outcomes in preterm infants born before 32 weeks of gestation. The main question it aims to answer is if the reactance z-score at 7 postnatal days adds to relevant clinical factors in the prediction of bronchopulmonary dysplasia. Participants will receive respiratory oscillometry measurements at 7 ± 2 postnatal days.

02

Conditions studied

  • Bronchopulmonary Dysplasia

Keywords

  • Respiratory oscillometry
  • Respiratory system reactance
  • Lung mechanics
  • Infant lung function testing
03

In context

Bronchopulmonary Dysplasia

339 studies on the registry are indexed under Bronchopulmonary Dysplasia; 80 are open to participants now.

This study's planned enrollment of 150 is close to the median of 137 across 92 observational studies indexed under Bronchopulmonary Dysplasia.

Browse Bronchopulmonary Dysplasia studies →

Lead sponsor

Fondazione IRCCS San Gerardo dei Tintori is the lead sponsor of 9 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Days to 9 Days
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Infants will be recruited from those admitted to tertiary-level neonatal intensive care units.

Inclusion criteria

  • born before 32 weeks post-menstrual age

Exclusion criteria

Exclusion Criteria:

  • congenital abnormalities
  • Inherited disorders of metabolism
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • no bronchopulmonary dysplasia

    Group of patients who do not receive the diagnosis of bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-mentrual age

    Diagnostic Test: Respiratory Oscillometry

  • bronchopulmonary dysplasia

    Group of patients developing bronchopulmonary dysplasia defined as the need for respiratory support at 36 weeks post-menstrual age.

    Diagnostic Test: Respiratory Oscillometry

Interventions

  • Diagnostic testRespiratory Oscillometry

    Measurement of respiratory system reactance by respiratory oscillometry

06

What researchers measure

Primary outcomes

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure

    Xrs will be expressed in z-score using reference equation for very preterm infants

    Time frame: Xrs will be measured at 7 days of life

Secondary outcomes

  1. Respiratory system reactance (Xrs) at the clinical positive end-expiratory pressure and ± 2 cmH2O

    Xrs will be expressed in cmH2O\*S/L

    Time frame: Xrs will be measured at 7 days of life

Other outcomes

  1. Respiratory support mode

    Respiratory support mode will be coded as 0 = no respiratory support, 1 = nasal high flow therapy, 2 = nasal CPAP or nasal IPPV, 3 = invasive mechanical ventilation

    Time frame: 7 postnatal days

  2. Fraction of inspired oxygen

    Time frame: 7 days of life

07

Study locations

6 of 6 sites recruiting
  • Medical University of Vienna
    Vienna, Wien 1090, Austria
    Enrolling by invitation
  • Fondazione IRCCS San Gerardo dei Tintori
    Monza, Monza E Brianza 20900, Italy
    Recruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milano, 20122, Italy
    Enrolling by invitation
  • Amsterdam UMC
    Amsterdam, Netherlands
    Enrolling by invitation
  • Uppsala University Children's Hospital
    Uppsala, S-751 85, Sweden
    Enrolling by invitation
  • Universitäts-Kinderspital beider Basel
    Basel, 4056, Switzerland
    Enrolling by invitation
08

References and documents

Publications

  • Zannin E, Neumann RP, Dellaca R, Schulzke SM. Forced oscillation measurements in the first week of life and pulmonary outcome in very preterm infants on noninvasive respiratory support. Pediatr Res. 2019 Sep;86(3):382-388. doi: 10.1038/s41390-019-0432-6. Epub 2019 May 20. PubMed 31108499 ↗
  • Veneroni C, Wallstrom L, Sindelar R, Dellaca' RL. Oscillatory respiratory mechanics on the first day of life improves prediction of respiratory outcomes in extremely preterm newborns. Pediatr Res. 2019 Feb;85(3):312-317. doi: 10.1038/s41390-018-0133-6. Epub 2018 Aug 4. PubMed 30127523 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05986032
Lead sponsor
Fondazione IRCCS San Gerardo dei Tintori
Collaborators
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, University Children's Hospital Basel, Uppsala University Hospital, Medical University of Vienna, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
Responsible party
Sponsor
First posted
Aug 14, 2023
Start date
Jul 15, 2023
Primary completion
Sep 3, 2024 (estimated)
Completion
Sep 24, 2024 (estimated)
Last update
Mar 6, 2024

Study contacts

Camilla Rigotti, PhD
Contact
dr.camilla.rigotti@gmail.com
+39039233 ext. 9173
Emanuela Zannin, PhD
Contact
emanuela.zannin@gmail.com
+393389323437
Camilla Rigotti, PhD
principal investigator · Fondazione IRCCS San Gerardo dei Tintori
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion